4-[4-(9H-carbazol-9-yl)-phenyl]diphenylamine | CAS:331980-55-3

We serve 4-[4-(9H-carbazol-9-yl)-phenyl]diphenylamine CAS:331980-55-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-[4-(9H-carbazol-9-yl)-phenyl]diphenylamine

Chemical Name:4-[4-(9H-carbazol-9-yl)-phenyl]diphenylamine
CAS.NO:331980-55-3
Synonyms:YGBA
4’-(9H-carbazol-9-yl)-N-phenyl-[1,1’-biphenyl]-4-amine
Molecular Formula:C30H22N2
Molecular Weight:410.50900
 
Specification:
Appearance:White to off-white powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like 4-[4-(9H-carbazol-9-yl)-phenyl]diphenylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4’-(9H-carbazol-9-yl)-N-phenyl-[1,1’-biphenyl]-4-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[4-(9H-carbazol-9-yl)-phenyl]diphenylamine Use and application,4-[4-(9H-carbazol-9-yl)-phenyl]diphenylamine technical grade,usp/ep/jp grade.


Related News: There’s a few factors that play into this.2,3-Dichloro-5-nitropyridine manufacturer Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.10-ACETOXY-1-CHLORODECANE supplier On Friday, US Health and Human Services Secretary Alex Azar declared the 2019 novel coronavirus a public health emergency and ordered any US citizens returning from the center of the outbreak in China to be quarantined for two weeks as a precaution.4-Nitrophenyl Trifluoroacetate vendor If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.”Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.